» Articles » PMID: 17100670

Increased Ventricular Ectopic Activity in Relation to C-reactive Protein, and NT-pro-brain Natriuretic Peptide in Subjects with No Apparent Heart Disease

Overview
Date 2006 Nov 15
PMID 17100670
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Subjects with frequent ventricular premature complexes (VPC) and no apparent heart disease make a heterogenic group with regard to prognosis. Some biomarkers have recently proved useful in risk stratification in different heart diseases. We examined prognostic impact of NT-Pro-brain natriuretic peptide (NT-Pro BNP), and C-reactive protein (CRP) in relation to frequent VPC in subjects with no apparent heart disease.

Methods: Six hundred seventy-eight healthy subjects between 55 and 75 years of age with no history of cardiovascular disease were included in the study. All were tested with fasting laboratory testing and 48-hour ambulatory ECG monitoring. Frequent VPC was defined as VPC > or =30/hour.

Results: In 56 subjects (8%) with frequent VPC the prognosis was much poorer compared to those without frequent VPC (Hazard ratio and 95% CI: 2.3;1.2-4.4, P = 0.01), after adjustment for conventional risk factors. In subjects with frequent VPC increased levels of CRP (above 2.5 microg/mL) was the only factor among the tested biomarkers, which was associated with a poor prognosis. Taking subjects without frequent VPC as reference, the hazard ratio and 95% CI for subjects with frequent VPC and increased CRP was 3.6;1.8-7.1, P = 0.0004, and for those with frequent VPC and normal CRP 0.8;0.2-3.5, P = 0.83, after correction for conventional risk factors.

Conclusions: Among middle-aged and elderly subjects with no apparent heart disease and frequent VPCs, a CRP value > or =2.5 microg/mL is associated with a significantly higher risk of death and acute myocardial infarction. These subjects deserve primary prevention measures and further work up for structural heart disease.

Citing Articles

Linking IL-6 and hsCRP among Indian patients with myocardial infarction.

Verma V, Sharma P, Singh S, Sarmah D, Patel R, Verma P Bioinformation. 2024; 20(4):378-385.

PMID: 38854770 PMC: 11161886. DOI: 10.6026/973206300200378.


Association of Longitudinal Changes in Cardiac Biomarkers With Atrial and Ventricular Arrhythmias (from the Atherosclerosis Risk in Communities [ARIC] Study).

Garg P, Norby F, Wang W, Krishnappa D, Soliman E, Lutsey P Am J Cardiol. 2021; 158:45-52.

PMID: 34465464 PMC: 8497411. DOI: 10.1016/j.amjcard.2021.07.043.


Classic and Novel Biomarkers as Potential Predictors of Ventricular Arrhythmias and Sudden Cardiac Death.

Shomanova Z, Ohnewein B, Schernthaner C, Hofer K, Pogoda C, Frommeyer G J Clin Med. 2020; 9(2).

PMID: 32093244 PMC: 7074455. DOI: 10.3390/jcm9020578.


Higher High-Sensitivity C Reactive Protein is Associated with Future Premature Ventricular Contraction: a Community Based Prospective Cohort Study.

Chen Y, Wu S, Li W, Wang B, Han X, Yang Y Sci Rep. 2018; 8(1):5152.

PMID: 29581482 PMC: 5979945. DOI: 10.1038/s41598-018-22868-8.


Biomarkers of cardiovascular injury and stress are associated with increased frequency of ventricular ectopy: a population-based study.

Brox Skranes J, Einvik G, Namtvedt S, Randby A, Hrubos-Strom H, Brynildsen J BMC Cardiovasc Disord. 2016; 16(1):233.

PMID: 27875987 PMC: 5118891. DOI: 10.1186/s12872-016-0407-z.